Please login to the form below

Not currently logged in
Email:
Password:

FDA warns web fraudsters over H1N1 claims

The US FDA has issued warning letters to more than 50 websites marketing products that claim to diagnose, prevent, treat or cure swine (H1N1) flu

The US Food and Drug Administration (FDA) has issued warning letters to more than 50 websites marketing products that claim to diagnose, prevent, treat or cure swine (H1N1) flu.

Teams from the FDA identified websites promoting and marketing products that had not been approved, authorised or cleared by the official body and pose a potential threat to public health. These included a shampoo that claimed to protect against the H1N1 virus, a spray claiming to leave a layer of virus-killing ionic silver on one's hands, and a 'new' supplement claiming to cure infection with the H1N1 virus in four to eight hours.

Over 50 letters have been issued by the agency warning the operators of such websites that they must not market products claiming to diagnose, mitigate, prevent, treat, or cure the 2009 H1N1 flu virus that are not approved, cleared, or authorised by the FDA. Over 66 per cent of the websites warned have now removed the offending products and/or claims. Details of offending websites were also posted on the FDA's website.

"We are committed to aggressively pursuing those who attempt to take advantage of a public health emergency by promoting and marketing unapproved, uncleared, or unauthorised products," said Dr Margaret A Hamburg, commissioner of food and drugs.

The warning letters were issued by email and requested a response within 48 hours. Failure by offending websites to act on the warnings may result in further civil or criminal enforcement action, including criminal prosecution, seizure and injunction. 


 

17th June 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics